2BB score and signals
Xeris Biopharma Holdings, Inc.’s current 2BB score is 35 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 12 | Very Low |
| Momentum | 48 | Stable |
| Financial strength | 58 | Normal |
| Quality | 100 | Very Strong |
| Risk | 3 | Very Low |
Company facts
| Headquarters | Chicago, Illinois, United States |
| Founded | 2005 |
| Employees | 435 |
| P/E ratio | 147.65 |
| 52-week range | $4.52 – $10.08 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2026-11-04 | — | 0.0323 | — | $103.38M |
| 2026-08-06 | — | 0.0034 | — | $92.03M |
| 2026-05-06 | — | -0.0051 | — | $82.29M |
| 2026-03-02 | — | 0.0449 | — | $83.99M |
2BBBullish & Bearish